fbpx
Skip to content

info@cv340b.org

Facebook page opens in new windowTwitter page opens in new windowLinkedin page opens in new windowYouTube page opens in new window
Community Voices 340B
Community Voices 340B
  • What is 340B?
    • FAQ
    • CV340B Campaign
  • Resources
    • Touchstones + Truths About 340B
    • #Defend340B Official Merchandise
    • Downloads + Information
  • Who We Are
    • Our Mission
    • Benefactor Program
  • News
  • Advocacy
    • REGISTER NOW: Second Annual Defend 340B March
    • Together for 340B Campaign Update: Hospitals
    • Show Your Support
    • Get Involved
      • Record a #Defend340B Video
      • Share Your #340BPower Story!
    • Join a Regional Advocacy Group
    • #Defend340B Official Merchandise
  • Contact Us
    • Send Us A Message + Subscribe
Search:
  • What is 340B?
    • FAQ
    • CV340B Campaign
  • Resources
    • Touchstones + Truths About 340B
    • #Defend340B Official Merchandise
    • Downloads + Information
  • Who We Are
    • Our Mission
    • Benefactor Program
  • News
  • Advocacy
    • REGISTER NOW: Second Annual Defend 340B March
    • Together for 340B Campaign Update: Hospitals
    • Show Your Support
    • Get Involved
      • Record a #Defend340B Video
      • Share Your #340BPower Story!
    • Join a Regional Advocacy Group
    • #Defend340B Official Merchandise
  • Contact Us
    • Send Us A Message + Subscribe

Daily Archives: January 3, 2018

CMS 340B Reimbursement Cuts Cause Big Pharma Profits While Underserved Patients Lose

340BBy Rhiannon KleinJanuary 3, 2018

As you and your readers may now be aware, the 340B Drug Pricing Program has been under siege for the past couple months. The program requires drug manufacturers to provide outpatient drugs to eligible health care organizations at significantly reduced prices, so that those savings can be passed on to the patients and the community…

Go to Top